Skip to main content
Monthly Archives

June 2019

Press Release

Calidi Biotherapeutics Announces The Appointment of Medical Oncologist and Expert in Oncolytic Immunotherapies, Dr. Dmitriy Zamarin to Their Scientific Advisory Board

SAN DIEGO (PRWEB) JUNE 03, 2019 - Calidi Biotherapeutics, Inc., a clinical‐stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, today announced the appointment of Dr. Dmitriy Zamarin, MD, Ph.D., to their scientific advisory board. Dr. Zamarin is an accomplished medical oncologist who…